D'Amico A V, Whittington R, Malkowicz S B, Schultz D, Schnall M, Tomaszewski J E, Wein A
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA.
J Clin Oncol. 1996 Jun;14(6):1770-7. doi: 10.1200/JCO.1996.14.6.1770.
To determine whether there is a role for endorectal coil magnetic resonance imaging (erMRI) in the prediction of pathologic stage, margin status, and/or postoperative prostate-specific antigen (PSA) failure in patients with clinically organ-confined prostate cancer.
Using erMRI, the radiologic-pathologic correlation of extracapsular extension (ECE) and seminal vesicle invasion (SVI) was evaluated in 445 surgically managed patients. Logistic regression multivariable analysis was applied to the clinical stage, PSA, biopsy Gleason grade, and erMRI findings to assess the outcomes of ECE, SVI, positive surgical margins (PSM), and postoperative PSA failure.
The accuracy of erMRI to predict for ECE and SVI numerically decreased with both increasing PSA and biopsy Gleason score because of the increasing false-negative scans in cases of microscopic transcapsular or seminal vesicle disease. Of patients who could not be categorized into low or high risk for postoperative PSA failure on the basis of clinical stage, preoperative PSA, and biopsy Gleason score, a negative or positive erMRI for ECE or SVI stratified these patients into groups with a 78% versus 21% (P < .0001) 3-year rate of actuarial freedom from PSA failure. In this subgroup, the overall accuracy of the erMRI was 70% +/- 6% and 94% +/- 2% for ECE and SVI, respectively. The most significant predictor on multivariable analysis of PSM was the erMRI finding of ECE (P = .0001).
This initial report suggests that a preoperative erMRI can identify clinically organ-confined prostate cancer patients at high risk for having ECE, SVI, and PSM that otherwise would be missed on the basis of the clinical stage, preoperative PSA, and biopsy Gleason score. Confirmatory studies are needed.
确定直肠内线圈磁共振成像(erMRI)在预测临床局限于器官的前列腺癌患者的病理分期、切缘状态和/或术后前列腺特异性抗原(PSA)失败方面是否具有作用。
使用erMRI,对445例接受手术治疗的患者进行了包膜外扩展(ECE)和精囊侵犯(SVI)的放射学-病理学相关性评估。将逻辑回归多变量分析应用于临床分期、PSA、活检Gleason分级和erMRI结果,以评估ECE、SVI、阳性手术切缘(PSM)和术后PSA失败的结果。
由于在微观包膜外或精囊疾病病例中假阴性扫描增加,随着PSA和活检Gleason评分的增加,erMRI预测ECE和SVI的准确性在数值上降低。对于那些根据临床分期、术前PSA和活检Gleason评分无法归类为术后PSA失败低风险或高风险的患者,ECE或SVI的erMRI阴性或阳性将这些患者分层为3年无PSA失败精算自由度分别为78%和21%(P <.0001)的组。在该亚组中,erMRI对ECE和SVI的总体准确性分别为70%±6%和94%±2%。PSM多变量分析中最显著的预测因素是erMRI发现的ECE(P =.0001)。
这份初步报告表明,术前erMRI可以识别出临床局限于器官的前列腺癌患者,这些患者有发生ECE、SVI和PSM的高风险,否则根据临床分期、术前PSA和活检Gleason评分会被漏诊。需要进行验证性研究。